[CLDX] YoY Quarter Result on 30-Sep-2012 [#Q3]

Stock
[CLDX] Celldex Therapeutics, Inc.
Announcement Date
02-Nov-2012
Financial Year
2012
Quarter
30-Sep-2012 [#Q3]
Profit Trend
QoQ- -9.10%
YoY- -27.65%
Quarter Report
CLDX's Result
CLDX's Financial Summary
View:
Show?
Quarter Result
30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 CAGR
Revenue 1,026 1,101 980 3,113 2,363 2,408 4,030 -20.38%
PBT -31,980 -28,082 -23,140 -15,027 -11,334 -8,755 -7,174 28.27%
Tax -782 -2,260 -142 -105 -288 -248 36 -
NP -31,980 -28,082 -23,140 -15,027 -11,772 -9,087 -7,174 28.27%
Tax Rate - - - - - - - -
Total Cost 33,006 29,183 24,120 18,140 14,135 11,495 11,204 19.72%
Ratio Analysis
30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 CAGR
NP Margin -3,116.96 -2,550.59 -2,361.22 -482.72 -498.18 -377.37 -178.01 61.10%
Per Share
30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 CAGR
EPS -4.87 -4.71 -4.28 -3.79 -4.00 -4.27 -6.78 -5.36%
EPS Diluted -4.87 -4.71 -4.28 -3.79 -4.00 -4.27 -6.78 -5.36%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.